Innovations leads £13.5m funding round in Precision Ocular

22 February 2016 – Imperial Innovations Group plc (AIM: IVO, ‘the Group’, ‘Innovations’) has led a £13.5 million investment round in Precision Ocular Ltd (Precision Ocular), a London-based retinal therapeutics company. Innovations has committed £6.9 million to the round alongside other investors, including Consort Medical plc, a leading global single source pharma services drug and

Read More »
Scroll to Top